Drug Profile
PF 755616
Alternative Names: PF-755616Latest Information Update: 03 Oct 2008
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 03 Oct 2008 Discontinued - Phase-I for Rheumatoid arthritis in USA (unspecified route)
- 20 Dec 2006 Phase-I clinical trials in Rheumatoid arthritis in USA (unspecified route)